CDMO News
Quantoom Biosciences Signs MoU with Univercells and Fiocruz for Second-Generation RNA Technologies
Quantoom Biosciences and Univercells have entered into a historic Memorandum of Understanding (MoU) with Brazil’s Fiocruz to enhance global health outcomes through RNA-based vaccines and therapies. The agreement was formalized during the Belgian Economic Mission to Brazil, with Her Royal